Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.
- 1 June 1969
- journal article
- Vol. 17 (6), 861-5
Abstract
Minimal inhibitory concentrations of rifampin for different species of mycobacteria were determined in 7H-10 agar medium and Lowenstein-Jensen egg medium. When rifampin was incorporated into egg medium, approximately 90% of its activity was lost. The stability of rifampin was tested during storage at different temperatures and concentrations. When tested in agar medium, a combination of isoniazid (INH) and rifampin inhibited multiple drug-resistant strains of Mycobacterium intracellulare, but under simulated in vivo conditions the drugs did not eliminate these same organisms. Drug-resistant mutants of M. intracellulare multiplied during an 8-day period when exposed 10 hr daily to the INH-rifampin regimen. However, combinations of rifampin and INH reduced drug-resistant mycobacterial populations by 99%, an effect which could not be enhanced by the addition of either erythromycin, ethionamide, or cycloserine.This publication has 7 references indexed in Scilit:
- Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis.Published by Elsevier ,1968
- Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.Published by Elsevier ,1968
- The antimycobacterial activity of rifampin.Published by Elsevier ,1968
- The rifamycins with other drugs in the treatment of pulmonary tuberculosis: A report of nine casesTubercle, 1967
- The susceptibility of mycobacteria to rifamide and rifampicinTubercle, 1967
- Preparation of Tuberculosis Susceptibility Testing Mediums by Means of Impregnated DisksAmerican Journal of Clinical Pathology, 1966
- [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].1963